AFG
BBH icon

Albion Financial Group’s VanEck Biotech ETF BBH Stock Holding History

Albion Financial Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$30K Buy
+175
New +$28.8K ﹤0.01% 285
2019
Q3 		– Sell
-9,597
Closed -$1.24M – 208
2019
Q2 		$1.24M Sell
9,597
-417
-4% -$51.4K 0.16% 88
2019
Q1 		$1.29M Sell
10,014
-145
-1% -$18.3K 0.17% 85
2018
Q4 		$1.13M Sell
10,159
-279
-3% -$33.7K 0.18% 86
2018
Q3 		$1.42M Sell
10,438
-326
-3% -$42.4K 0.19% 80
2018
Q2 		$1.29M Sell
10,764
-304
-3% -$35.8K 0.19% 83
2018
Q1 		$1.33M Sell
11,068
-196
-2% -$24.6K 0.2% 78
2017
Q4 		$1.4M Sell
11,264
-644
-5% -$82.2K 0.21% 78
2017
Q3 		$1.6M Sell
11,908
-343
-3% -$44.7K 0.24% 69
2017
Q2 		$1.54M Sell
12,251
-593
-5% -$71.5K 0.26% 65
2017
Q1 		$1.53M Sell
12,844
-1,182
-8% -$138K 0.23% 65
2016
Q4 		$1.51M Buy
14,026
+702
+5% +$76.3K 0.25% 66
2016
Q3 		$1.53M Buy
13,324
+778
+6% +$88.7K 0.26% 67
2016
Q2 		$1.28M Sell
12,546
-194
-2% -$20.7K 0.23% 60
2016
Q1 		$1.32M Sell
12,740
-28
-0.2% -$2.92K 0.22% 60
2015
Q4 		$1.62M Buy
12,768
+179
+1% +$21.9K 0.28% 48
2015
Q3 		$1.44M Sell
12,589
-781
-6% -$103K 0.26% 53
2015
Q2 		$1.8M Sell
13,370
-174
-1% -$23.1K 0.3% 46
2015
Q1 		$1.75M Sell
13,544
-1,186
-8% -$149K 0.3% 43
2014
Q4 		$1.7M Sell
14,730
-11,582
-44% -$1.31M 0.29% 44
2014
Q3 		$2.79M Buy
26,312
+1,920
+8% +$194K 0.49% 34
2014
Q2 		$2.33M Buy
24,392
+889
+4% +$79.7K 0.4% 43
2014
Q1 		$2.14M Buy
23,503
+1,226
+6% +$119K 0.39% 45
2013
Q4 		$1.97M Sell
22,277
-321
-1% -$26.8K 0.37% 45
2013
Q3 		$1.87M Buy
22,598
+708
+3% +$55.6K 0.4% 43
2013
Q2 		$1.5M Buy
+21,890
New +$1.52M 0.33% 45

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Albion Financial Group's BBH Position: Q4 2020 in Review

Albion Financial Group opened a new position in VanEck Biotech ETF (BBH) in Q4 2020: 175 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #285 among its holdings. This is a return to the name: Albion Financial Group previously reported a position in BBH as recently as Q2 2019.

Albion Financial Group first reported a position in BBH in Q2 2013 and has held it in 26 quarters since. The position peaked at $2.79M in Q3 2014. 108 funds tracked by Wall St. Rank hold BBH as of Q4 2020.

  • Albion Financial Group held 175 shares of VanEck Biotech ETF worth $30K as of Q4 2020.
  • VanEck Biotech ETF was a new Albion Financial Group position in Q4 2020.
  • VanEck Biotech ETF made up ﹤0.01% of Albion Financial Group's portfolio in Q4 2020, its #285 holding.
  • Albion Financial Group first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 26 quarters since.
  • Albion Financial Group's VanEck Biotech ETF position peaked at $2.79M in Q3 2014.
  • 108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2020.

Based on Albion Financial Group's 13F filing for Q4 2020, filed 19 Feb 2021.